InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-19 · accession 0001209191-23-043166 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-21 2023-07-20 WGS Saad Kareem Chief Transformation Off S - Sale+OE $7.85 -163 12.4K -1% -$1,280
D 2023-07-21 2023-07-19 WGS Saad Kareem Chief Transformation Off M - OptEx — +546 12.6K +5% —
D 2023-07-21 2023-07-19 WGS Saad Kareem Chief Transformation Off M - OptEx $0.00 -546 3,821 -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-07-20 S D 163 $7.85 12,442 D — —
2 Common Class A Common Stock 2023-07-19 M A 546 — 12,605 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2023-07-19 M D 546 $0.00 3,821 D — · — to — 546 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 3/16th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on January 19, 2022, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on January 19, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.